Fast growing life sciences company new tenant at Technology Business Center
CHICAGO, Nov. 15 /PRNewswire/ -- Chromatin, Inc. has signed a lease to move its headquarters and its molecular biology research and development operations to the Technology Business Center (TBC) at University Technology Park At IIT (UTP), it was announced today.
Chromatin develops and markets novel proprietary technology that was first developed at the University of Chicago. The company's technology enables entire chromosomes to be designed and incorporated into plant cells. These mini-chromosomes can be used in any plant to simultaneously introduce multiple genes while maintaining precise control of gene expression. Chromatin's mini-chromosome technology can be used to deliver genes that benefit the agricultural, nutritional, energy, pharmaceutical, and chemical sectors. Visit http://www.chromatininc.com for more information.
"UTP is a great setting for our research and provides access to excellent facilities and connections to the City of Chicago and IIT," said Daphne Preuss, Chromatin's CEO and co-founder. "We are experiencing significant growth and UTP provides capacity for our current and future needs."
"We're delighted to welcome Chromatin to UTP," said David Baker, UTP Executive Director. "Our goal is to bring businesses like this to the park in order to foster and promote research in the life sciences and technology and help keep growing technology companies in Chicago."
Chromatin's lease includes options to extend the term and to expand into additional space. Chromatin's recent licensing agreements with leading agriculture companies, as well as the company's newer activities in the biofuels sector, are expected to spur this growth.
Chromatin will join more than 20 technology companies now calling UTP
home. These companies, ranging from start-ups employing two individuals to
the North Amer
|SOURCE Illinois Institute of Technology|
Copyright©2007 PR Newswire.
All rights reserved